Elisheva Eisenberg
Papers
1
Total Citations
7
H-Index
1
About
Dr. Elisheva Eisenberg is a leading voice in hereditary cancer risk assessment and surgical decision-making, with a focused expertise in the psychosocial and clinical complexities of risk-reducing mastectomy (RRM) for germline pathogenic variant carriers. Her most cited work, the 2024 "Counselling Framework for Germline BRCA1/2 and PALB2 Carriers Considering Risk-Reducing Mastectomy," has already garnered 7 citations, establishing a new standard for patient-centered care. In this seminal paper, Dr. Eisenberg provides a structured approach to quantifying residual lifetime breast cancer risk and the absolute benefit of RRM, addressing a critical gap in how clinicians communicate nuanced risk data to women facing life-altering preventive surgery. Her research bridges oncology, genetics, and counseling psychology, ensuring that carriers of BRCA1/2 and PALB2 variants receive not only statistical clarity but also empathetic support. By developing this framework, Dr. Eisenberg has empowered both patients and providers to navigate the profound decision of RRM with greater confidence and precision. Her work stands as a vital resource for researchers and clinicians dedicated to improving outcomes in hereditary cancer prevention.
Research Focus
Key Achievements
Top Papers
- 1